Enmetazobactam

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 3 records

Enmetazobactam 3 markets · 3 records Forms
Filters
MarketGB 1ES 1EU 1
Kind

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

  • 500 mg per mL / per unit basis not statedinjection CombinationCefepime 2,000 mg + Enmetazobactam 500 mgExblifep 2g/0.5g powder for concentrate for solution for infusion vials

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Combination products containing this ingredient

  • 500 mg per mL / per unit basis not statedinjection CombinationCefepime 2,000 mg + Enmetazobactam 500 mgEXBLIFEP

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.